Core Viewpoint - The control change of *ST Jinbi has been terminated, leading to a significant impact on the company's stock price and financial outlook, with a projected net loss for the first half of 2025. Group 1: Control Change Announcement - *ST Jinbi announced the termination of the control change agreement with Yuan Yi Cheng Wu Technology Co., Ltd., which was initially set to transfer 13.3% of the company's shares [1][3] - The termination was due to uncertainties arising from family asset liquidation disputes involving Yuan Yi Cheng Wu's actual controller, leading both parties to agree to halt the transaction [2][3] Group 2: Financial Performance Forecast - The company expects a revenue of approximately 160 million to 170 million yuan for the first half of 2025, representing a year-on-year growth of 104.45% to 117.23% [5] - However, the net profit is projected to be a loss of 8 million to 16 million yuan, indicating an increase in losses compared to the previous year [5] Group 3: Market Reaction and Future Plans - Following the announcement of the control change, *ST Jinbi's stock price experienced consecutive limit-ups, but the termination of the control change has raised concerns in the market [5] - The company plans to continue focusing on emerging industries to seek new growth points for performance improvement [4]

Group 1 - The company, Jinfa Labi, expects a significant increase in revenue for the first half of 2025, projecting an estimated revenue of 78.26 million yuan, representing a growth of 104.45% to 117.23% compared to the same period last year [1] - The company anticipates a net loss attributable to shareholders ranging from 8 million to 16 million yuan, which is a decline of 190.50% to 481.00% compared to a loss of 2.75 million yuan in the previous year [1] - The basic earnings per share are expected to be a loss of 0.02 to 0.05 yuan per share, compared to a loss of 0.01 yuan per share in the same period last year [1] Group 2 - The company reported that its outpatient department generated approximately 33 million yuan in revenue for the first half of 2025, indicating a substantial increase [1] - Despite a significant reduction in losses from its investment company, the company still faces some level of loss, which must be recognized according to its shareholding ratio [1] - The company has upgraded its IP image, which is gradually being applied to products and packaging, and is accelerating the promotion of old products to recover funds [1]

Core Viewpoint - The share transfer agreement and voting rights waiver agreement between the controlling shareholders of *ST Jinbi and Shanghai Yuanyi Chengwu Technology Co., Ltd. have been terminated as of July 11, 2025, due to family asset liquidation disputes involving the acquirer [1] Summary by Relevant Sections - The controlling shareholders, Lin Haoliang and Lin Ruowen, intended to transfer a total of 13.30% of shares, comprising 6.82% from Lin Haoliang and 6.48% from Lin Ruowen, for a total consideration of 346 million yuan [1] - The termination of the agreements means that the current controlling shareholders remain Lin Haoliang and Lin Ruowen [1]

证券代码：002762 证券简称：*ST金比 公告编号：2025-039号 关于公司控股股东、实际控制人终止协议转让暨 终止控制权变更的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或者重大遗漏。 金发拉比妇婴童用品股份有限公司（以下简称"公司"）于 2025 年 7 月 11 日收到公司控股股东、实控人林浩亮先生、林若文女士发来的《告知函》，获悉 其于 2025 年 6 月 11 日与上海元一成物科技有限公司所签署的《股份转让协议》、 《表决权放弃协议》暨公司控制权拟发生变更事项的相关交易于 2025 年 7 月 11 日终止。现将有关事项公告如下： 一、本次股份协议转让事项概述 2025 年 6 月 11 日，公司控股股东、实际控制人林浩亮先生（以下简称"甲 方一"）、林若文女士（以下简称"甲方二"）与元一成物（即"乙方"）签署了《股 份转让协议》。林浩亮先生拟向元一成物转让其持有的公司无限售条件流通股 24,134,838 股，占公司总股本的 6.82%；林若文女士拟向元一成物转让其持有的 公司无限售条件流通股 22,950,487 股，占公司总股本的 6.4 ...

Group 1 - The core point of the article is that *ST Jinbi (002762.SZ) announced the termination of the share transfer and voting rights waiver agreements with Shanghai Yuanyi Chengwu Technology due to uncertainties arising from the acquirer's family asset liquidation disputes [1] - The termination of the agreements will not impact the company's governance or daily operations, and the company will continue to operate steadily while seeking new growth points [1]

Revenue Expectations - The company expects revenue for the first half of 2025 to be between 160 million and 170 million yuan, representing a year-on-year growth of 104.45% to 117.23% compared to 78.26 million yuan in the same period last year[3]. - The service segment, including Zhuhai Hanfei Medical Beauty Clinic and Zhongshan Hanfei Medical Beauty Clinic, is expected to generate approximately 33 million yuan in revenue for the first half of 2025[5]. - The company has increased investment in e-commerce channels and adjusted product structure to drive revenue growth[5]. Profit Projections - The net profit attributable to shareholders is projected to be a loss of 8 million to 16 million yuan, a decline of 190.50% to 481.00% from a loss of 2.75 million yuan in the previous year[3]. - The net profit after deducting non-recurring gains and losses is also expected to be a loss of 8 million to 16 million yuan, down 177.33% to 454.67% from a loss of 2.88 million yuan last year[3]. - The basic earnings per share are anticipated to be a loss of 0.02 to 0.05 yuan per share, compared to a loss of 0.01 yuan per share in the same period last year[3]. Investment and Market Conditions - The company’s investment in Guangdong Hanfei Hospital is expected to show reduced losses, but still incur some losses due to market conditions[5]. - The company is upgrading its IP image for application in products and packaging, and is accelerating promotions for older products to recover funds[5]. Financial Reporting and Risks - The financial data in the earnings forecast has not been audited by an accounting firm and is based on preliminary estimates by the company's finance department[7]. - Investors are advised to pay attention to investment risks as the specific data will be detailed in the 2025 semi-annual report[7].

Group 1 - The childcare service concept sector rose by 1.82%, leading the concept sectors in terms of growth, with 13 stocks increasing in value [1][2] - Notable gainers in the sector included Huamei Holdings, which hit the daily limit, and other companies like Dou Shen Education, Hejing Technology, and Chuangyuan Co., which rose by 5.98%, 5.55%, and 4.21% respectively [1][2] - The sector experienced a net outflow of 243 million yuan in main funds, with Dou Shen Education receiving the highest net inflow of 69.37 million yuan [2][3] Group 2 - The top three stocks in terms of net inflow ratio were Chuangyuan Co. at 4.71%, Huamei Holdings at 3.96%, and Zhongyuan Media at 3.49% [3] - Stocks with significant declines included Tuo Wei Information, *ST Jinke, and Yuexin Health, which fell by 1.42%, 1.34%, and 1.15% respectively [1][2] - The overall market showed mixed performance, with various sectors experiencing both gains and losses, highlighting the volatility in the current investment landscape [2][4]

Market Performance - The hair medical concept sector rose by 2.34%, ranking 10th among concept sectors, with 19 stocks increasing in value, including JiuZhiTang which hit the daily limit, and TianEnKang, KangHui Pharmaceutical, and KangYuan Pharmaceutical which rose by 6.42%, 5.16%, and 4.55% respectively [1] - The top gainers in today's market include the fruit index at 4.73%, PCB concept at 3.27%, and AI mobile at 2.92%, while the military restructuring concept saw a decline of 1.49% [1] Capital Flow - The hair medical concept sector experienced a net inflow of 219 million yuan, with 11 stocks receiving net inflows, and 5 stocks seeing inflows exceeding 10 million yuan. JiuZhiTang led with a net inflow of 172 million yuan, followed by ShuiYang Co., KangYuan Pharmaceutical, and NengTe Technology with net inflows of 34.25 million yuan, 21.05 million yuan, and 13.44 million yuan respectively [1] - In terms of capital inflow ratios, JiuZhiTang, ShuiYang Co., and KangHui Pharmaceutical had the highest net inflow rates at 33.17%, 6.81%, and 6.15% respectively [2] Stock Performance - JiuZhiTang saw a significant increase of 10.06% with a turnover rate of 7.62%, while ShuiYang Co. and KangYuan Pharmaceutical increased by 3.12% and 4.55% respectively [2] - Stocks such as *ST JinBi and AoYang Health experienced declines of 0.69% and 0.26% respectively, indicating some volatility within the sector [1][3]

综合授信额度的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏。 金发拉比妇婴童用品股份有限公司（以下简称"公司"）第五届董事会第十八次 会议和第五届监事会第十六次会议审议通过了《关于 2025 年度向相关金融机构申请 综合授信额度的议案》，同意公司向相关金融机构申请累计不超过人民币 4 亿元或等 值外币的授信额度。 根据公司的经营发展规划及业务发展需求，拟向相关金融机构申请授信额度，公 司及纳入公司合并报表范围的子公司 2025 年度向相关金融机构申请总额不超过人民 币 4 亿元或等值外币的的综合授信额度。 综合授信品种包括但不限于：短期流动资金贷款、长期借款、银行承兑汇票、商 业承兑汇票、保函、信用证、抵押贷款等。 具体融资金额及品种将视公司业务发展的实际需求来合理确定。授信期限从本次 董事会审议通过之日起至 2025 年年度股东大会召开日止，授信期限内授信额度可循 环使用。董事会授权公司董事长负责具体办理上述授信额度的申请事宜，并签署相关 法律文件。 证券代码：002762 证券简称：*ST金比 公告编号：2025-035号 金发拉比妇婴童用品股份有 ...

目前公司购买的上述现金管理产品已到期，截至本公告发出日，上述现金管理产品本金 8,700 万元及收益 501,181.94 元已收回至本公司账户。 证券代码：002762 证券简称：*ST金比 公告编号：2025-037号 金发拉比妇婴童用品股份有限公司 关于按期收回现金管理产品本金及收益的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记载、误导 性陈述或重大遗漏。 金发拉比妇婴童用品股份有限公司（以下简称"公司"）第四届董事会第三次会议审议 通过了《关于调整闲置自有资金现金管理额度的议案》，同意公司使用自有资金总额不超过 45,000 万元进行现金管理，购买商业银行等金融机构发行的安全性高、流动性好、有合适收 益的现金管理产品，自有资金在上述额度内可循环使用。现将公司购买的已到期现金管理产品 及收益情况公告如下： | 机构名称 | 产品类 | 资金 | 收益起算 | | 产品到期 | 投资期限（天） | 赎回本金（万元） | 收益金额（元） | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | 型 | 来源 | ...